< Back to search
Filter
1

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma,
Location: Boston MA, Fairfax VA, Pittsburgh PA, Dallas TX
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT04370587

Phase1, Phase2, Recruiting

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

for
HNSCC, HNSCC,Larynx, Pharynx and Oral Cavity,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06819228

Phase1, Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors

for
Solid Tumor, HNSCC, RCC, CRC
Location: Jacksonville FL, Rochester MN, Scottsdale AZ,
Sponsor: SparX Biotech(Jiangsu) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06259552

Phase1, Recruiting

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for
Advanced Solid Tumor, PDAC, HNSCC
Location: Boston MA, New Haven CT, New York NY, St Louis MO,
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT06597721

Phase1, Recruiting
New

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

for
Selected Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Glen Burnie MD
Sponsor: SK Life Science, Inc.

Sex: All

Age: 18+

Code: NCT07812805

Phase1, Recruiting

Interested in new head and neck squamous cell carcinoma (hnscc) trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

High-Resolution PET-CT Imaging for Surgical Margin Visualization

for
Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06915454

Recruiting

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

for
Melanoma, NSCLC, Hepatocellular Carcinoma, Urothelial Cancer,
Location: Pittsburgh PA
Sponsor: Dan Zandberg

Sex: All

Age: 18+

Code: NCT04114136

Phase2, Recruiting

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

for
Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer,
Location: Houston TX
Sponsor: Critical Outcome Technologies Inc.

Sex: All

Age: 18+

Code: NCT02433626

Phase1, Recruiting

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC,
Location: Fairfax VA, Tampa FL, Farmington Hills MI,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07085091

Phase1, Recruiting

Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC

for
Squamous Cell Carcinoma, Head and Neck Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06137274

Phase2, Recruiting

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

for
Small Cell Lung Cancer Extensive Stage, Brain Metastases,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07139990

Phase1, Recruiting